Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Gyrate Atrophy

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Gyrate Atrophy:

Pubmed Logo
[Development of disease-specific patient groups within Pro Retina]
The formation, development and external impact of the following eight...
9th October, 2009
Klinik fur Augenheilkunde, , Charite - Universitatsmedizin Berlin, Campus Ophthalmologe. 2009 Jul;106(7):639-45.
DOI Direct Link
Retinal detachment causing unilateral blindness in a 12-year-old girl with gyrate atrophy.
OBJECTIVE: To evaluate the association between pubertal gynecomastia and...
17th September, 2009
Division of Clinical and Metabolic Genetics, The Hospital for Sick J Inherit Metab Dis. 2009 Oct;32(5):670-1.
DOI Direct Link
Clinical Applications of Creatine Supplementation on Paediatrics.
Creatine plays a central role in energy metabolism and is synthesized in...
16th September, 2009
4th Department of Pediatrics, Aristotle University, Thessaloniki, Greece. Curr Pharm Biotechnol. 2009 Nov 1;10(7):683-690.
Secondary creatine deficiency in ornithine delta-aminotransferase deficiency.
AIMS: Ornithine delta-aminotransferase (OAT) deficiency causes gyrate...
3rd July, 2009
Reference Center for Metabolic Disorders, Necker - Enfants Malades Mol Genet Metab. 2009 Jun;97(2):109-13. Epub 2009 Mar 31.
DOI Direct Link
Nutritional therapies for ocular disorders: Part Three.
Parts one and two of this series discussed nutritional and botanical...
17th December, 2008
Altern Med Rev. 2008 Sep;13(3):191-204.

View more research publications.

Press Releases About Gyrate Atrophy:

BioPortfolio Logo
Repligen Reports Second Quarter Fiscal Year 2010 Financial Results 5th November, 2009 Repligen Corporation
WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the
Families of Spinal Muscular Atrophy Licenses Potential Treatment for SMA to Repligen Corporation 22nd October, 2009 Families of Spinal Muscular Atrophy
ELK GROVE VILLAGE, Ill., Oct. 22 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy (FSMA) announced today that it has entered into a groundbreaking exclusive license agreement with
Repligen Licenses Potential Treatment for Spinal Muscular Atrophy 22nd October, 2009 Repligen Corporation
WALTHAM, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that it has entered into an exclusive license agreement with Families of Spinal Muscular Atrophy
Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 3rd September, 2009 Reportlinker
-- Analyzes the market outlook, trends, and challenges. Chapter-1: SUMMARY SUMMARY TABLE WORLDWIDE POTENTIAL MARKET FOR MEMORY/COGNITION THERAPEUTICS, BY DISEASE AREA, THROUGH 2014 ($
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs 19th June, 2009 Families of Spinal Muscular Atrophy
LIBERTYVILLE, Ill., June 18 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy has just released details of the latest developments for the Families of SMA funded therapeutic pipeline.

BioNews Results for Gyrate Atrophy:

RSS Logo
BioPortfolio Logo
White Matter Lesions and Lacunar Infarcts Are Independently and Differently Associated with Brain Atrophy: The SMART-MR Study
MDLinx:  Nov 18 2009 12:28PM Matching: atrophy
Cancer: Findings from University of Liverpool advance knowledge in cancer
NewsRX:  Nov 15 2009 6:05AM Matching: atrophy
Unique Therapeutic Candidate To Treat Spinal Muscular Atrophy Identified
MedIndia:  Nov 9 2009 1:27PM Matching: atrophy
Medical News: Drug Candidate For Treating Spinal Muscular Atrophy Identified By Researchers
BioFind:  Nov 5 2009 3:57PM Matching: atrophy
Drug Candidate For Treating Spinal Muscular Atrophy Identified By Researchers
Medical News Today:  Nov 5 2009 12:44PM Matching: atrophy
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Gyrate Atrophy Patents:

USPTO Logo
US Patent No.Title
5326569 Medical foods for the nutritional support of child/adult metabolic diseases
6093699 Method for gene therapy involving suppression of an immune response
6140314 Selective and non-invasive visualization or treatment of vasculature
6204251 Ocular gene therapy
6225291 Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Gyrate Atrophy scientists - we have details of around 28 individuals working on Gyrate Atrophy .


This page has been viewed 374 times
Recent Search Terms used to find this page: Gyrate atrophy | gyrate atrophy | gyrate atrophy | gyrate atrophy research | gyrate atrophy wikipedia | gyrate atrophy and OCT | gyrate atrophy | gyrate atrophy research | gyrate atrophy | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Gyrate Atrophy across BioPortfolio, or for Gyrate Atrophy Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.